We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
-1.19%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$4.26B
AUM Growth
-$118M
Cap. Flow
+$932M
Cap. Flow %
21.89%
Top 10 Hldgs %
73.27%
Holding
299
New
5
Increased
187
Reduced
15
Closed
28

Top Buys

Rank Stock Value
1
CAT icon
Caterpillar
CAT
+$4.87M
2
SCCO icon
Southern Copper
SCCO
+$4.86M
3
OKE icon
Oneok
OKE
+$3.88M
4
MSFT icon
Microsoft
MSFT
+$3.87M
5
EPD icon
Enterprise Products Partners
EPD
+$3.66M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$35.8M
2
LLY icon
Eli Lilly
LLY
+$32.9M
3
IT icon
Gartner
IT
+$18.4M
4
BNTX icon
BioNTech
BNTX
+$2.75M
5
ENTG icon
Entegris
ENTG
+$1.85M

Sector Composition

Rank Sector Weight
1 Healthcare 51.19%
2 Technology 7.33%
3 Energy 7.29%
4 Utilities 4.99%
5 Consumer Discretionary 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOCU
276
DocuSign
DOCU
$9.63B
– –
-9,053
Closed -$705K
DT icon
277
Dynatrace
DT
$12.1B
– –
-16,566
Closed -$915K
ENTG icon
278
Entegris
ENTG
$19.7B
– –
-22,947
Closed -$1.85M
ESTC icon
279
Elastic
ESTC
$6.1B
– –
-16,924
Closed -$1.43M
FLYW icon
280
Flywire
FLYW
$1.96B
– –
-25,609
Closed -$300K
FTV icon
281
Fortive
FTV
$19B
$0 ﹤0.01%
3
– –
INSM icon
282
Insmed
INSM
$23.2B
– –
-17,191
Closed -$1.73M
IOVA icon
283
Iovance Biotherapeutics
IOVA
$2.23B
– –
-10,700
Closed -$18K
IRON icon
284
Disc Medicine
IRON
$2.83B
– –
-30,635
Closed -$1.62M
KVUE icon
285
Kenvue
KVUE
$37B
$0 ﹤0.01%
15
– –
NICE icon
286
Nice
NICE
$5.29B
– –
-4,974
Closed -$840K
NOG icon
287
Northern Oil and Gas
NOG
$2.3B
– –
-589
Closed -$17K
NRIX icon
288
Nurix Therapeutics
NRIX
$2.43B
– –
-122,782
Closed -$1.4M
OLO
289
DELISTED
Olo Inc
OLO
– –
-9,510
Closed -$85K
OMCL icon
290
Omnicell
OMCL
$1.86B
$0 ﹤0.01%
1
– –
PD icon
291
PagerDuty
PD
$700M
– –
-94,658
Closed -$1.45M
RVTY icon
292
Revvity
RVTY
$12.3B
– –
-18,439
Closed -$1.78M
SLDB icon
293
Solid Biosciences
SLDB
$771M
– –
-361,660
Closed -$1.76M
TENB icon
294
Tenable Holdings
TENB
$3.56B
– –
-34,277
Closed -$1.16M
TYL icon
295
Tyler Technologies
TYL
$12.2B
– –
-1,462
Closed -$867K
VERA icon
296
Vera Therapeutics
VERA
$2.54B
– –
-64,042
Closed -$1.51M
VTRS icon
297
Viatris
VTRS
$20.1B
$0 ﹤0.01%
29
– –
W icon
298
Wayfair
W
$11.1B
– –
-25
Closed -$1K
WHR icon
299
Whirlpool
WHR
$2.42B
– –
-47
Closed -$5K
8 9 10 11
12

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Bollard Group's Q3 2025 Portfolio in Review

As of Q3 2025, Bollard Group held 299 positions worth $4.26B, down 2.7% from $4.37B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Bollard Group deployed $932M of net new capital in Q3 2025, opening 5 new positions and adding to 187 existing holdings. Its largest new stake was Tortoise North American Pipeline ETF: 68,861 shares worth $2.51M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 56% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Boston Scientific, an estimated $35.8M trimmed.

  • Bollard Group's largest Q3 2025 buy was Tortoise North American Pipeline ETF: 68,861 shares worth $2.51M.
  • Bollard Group added most to Caterpillar in Q3 2025, an estimated $4.87M increase.
  • Bollard Group's biggest Q3 2025 reduction was Boston Scientific, cutting an estimated $35.8M.
  • Bollard Group fully exited BioNTech in Q3 2025, selling an estimated $2.75M.
  • Bollard Group's ten largest holdings make up 73% of its $4.26B portfolio in Q3 2025.
  • Bollard Group opened 5 new positions and closed 28 in Q3 2025.
  • Bollard Group's portfolio value fell 2.7% quarter-over-quarter to $4.26B.

Based on Bollard Group's 13F filing for Q3 2025, filed 14 Nov 2025.